Why Wall Street shaved a third of Peninsula cancer cell therapy company's value despite good news
Four of six acute myeloid leukemia patients had "complete responses" to the company's "natural killer" cell therapy in combination with two chemotherapy drugs.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Health Management | Leukemia | Pharmaceuticals